Literature DB >> 15461628

Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder.

Eleni Tholouli1, Charles R M Hay, Peter O'Gorman, Michael Makris.   

Abstract

Acquired Glanzmann's thrombasthenia (GT) is an uncommon accompaniment to immune thrombocytopenic purpura. Rarely, GT may present as an acquired autoimmune disorder of platelet function, with rapid onset of a moderate-to-severe bleeding tendency, a prolonged bleeding time, but with a normal platelet count and normal platelet glycoprotein (GP) expression. This is caused by an autoantibody with specificity for platelet GP IIb/IIIa or an epitope close to that of the GP, resulting in partial or complete refractoriness of the patient's platelets to ADP, collagen and arachidonic acid. We describe two patients with acquired GT and a normal platelet count, who presented with severe bleeding. The first patient responded gradually to immunosuppressive treatment but eventually developed non-Hodgkin's lymphoma. The second patient had no other underlying conditions and remitted spontaneously within 2 years.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461628     DOI: 10.1111/j.1365-2141.2004.05173.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Integrins and their role in megakaryocyte development and function.

Authors:  Xiaosheng Yang; Shlok V Chitalia; Shinobu Matsuura; Katya Ravid
Journal:  Exp Hematol       Date:  2021-12-12       Impact factor: 3.249

Review 2.  Glanzmann thrombasthenia.

Authors:  Alan T Nurden
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

3.  Glanzmann's Thrombasthenia Diagnosed following Knee Arthroscopy.

Authors:  John E Zvijac; Sharhabil S Ammus; Fernando Aran; Gary M Kiebzak
Journal:  Case Rep Orthop       Date:  2015-04-27

4.  Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report.

Authors:  Elizabeth Sarah Mayne; Malcolm Tait; Barry Frank Jacobson; Evashin Pillay; Susan J Louw
Journal:  Thromb J       Date:  2018-11-26

Review 5.  Glanzmann thrombasthenia: genetic basis and clinical correlates.

Authors:  Juliana Perez Botero; Kristy Lee; Brian R Branchford; Paul F Bray; Kathleen Freson; Michele P Lambert; Minjie Luo; Shruthi Mohan; Justyne E Ross; Wolfgang Bergmeier; Jorge Di Paola
Journal:  Haematologica       Date:  2020-03-05       Impact factor: 9.941

6.  Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center.

Authors:  Ganesh Kasinathan; Jameela Sathar
Journal:  Blood Res       Date:  2021-12-31

Review 7.  Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease.

Authors:  Monica Bacci; Antonietta Ferretti; Marina Marchetti; Maria A Alberelli; Anna Falanga; Corrado Lodigiani; Erica De Candia
Journal:  Blood Transfus       Date:  2022-01-08       Impact factor: 5.752

8.  Clinical Management of Glanzmann's Thrombasthenia: A Case Report.

Authors:  Indu Varkey; Kavita Rai; Amitha M Hegde; Mangalpady Shenoy Vijaya; Vinod Idicula Oommen
Journal:  J Dent (Tehran)       Date:  2014-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.